Fear of cancer recurrence is related to the efficacy of immunotherapy and quality of life in patients with NSCLC during the COVID-19 pandemic in China.

Xiangxiang Yin(Central South University), Huaidong Cheng(Southern Medical University Shenzhen Hospital), Sheng Yu(Anhui Medical University), Yuhang Cheng(Chinese Academy of Sciences), Senbang Yao(Anhui Medical University), Yanyan Jing(Tianjin University of Traditional Chinese Medicine), Lingxue Tang(Anhui Medical University), Wen Li(First Affiliated Hospital of Xi'an Jiaotong University), Lulian Pang(Anhui Medical University), Junxu Wu(Anhui Medical University), Shaochun Liu(Harbin Medical University)
PubMed
January 1, 2022
Cited by 2


Related Papers